Have You Met Glunovo?

Bloodless Glucometer Device As a diabetic, protecting yourself from sugar fluctuations means protecting yourself from the complications of this disease.

This is a new product that is much more different from other continuous Glucose Measurement Systems; With the new generation Bluetooth Technology, a revolution has been created in glucose measurement.

Unlike its other peers, the Bluetooth Transmitter is guaranteed for a lifetime > 3 years and can be used for longer periods of time. Thus, the costs of long-term continuous glucose measurement are considerably reduced. There is no such thing as throwing away and repurchasing the Bluetooth Transmitter every 2 months. It can be used repeatedly used.

In clinical studies, the deviation value was found to be quite low when compared to hospital measurements. Value differences between 1% and 6% (MARD 9%) were detected. This is perceived naturally as tissue sugar is measured.

As stated by all Endocrine Specialists, the possibility of calibration at all times provides serious privileges to the device. Because although bloodless glucose measurement is at the forefront, it is more important to catch the most accurate measurement and ensure its continuity. The aim of continuous glucose measurement is to prevent sugar fluctuations and complications related to long-term diabetes. This is ensured by accurate and continuous measurement.

With the punctual Glunovo continuous glucometer system, the sugar level is measured day and night, every 3 minutes. In case of excessive decrease or increase in sugar, the patient or patient relatives are called by phone using VoIP technology. Even if the patient is asleep. So the phone is not expected to give just a simple alarm. When the patient is woken up by phone, a digital call center warns that "Your sugar is very low. Please intervene". If the patient cannot wake up, the person he refers to as (close relative, friend, etc.) is called by phone. This function may be very important especially in cases of Insulin-dependent Type 1 Diabetes pediatric patients.